IVERIC bio, Inc.: 10-Q filed 2015-11-05
What IVERIC bio, Inc. reported in its quarterly report filed 2015-11-05 (fiscal Q3 2015): 30 published measures, 91 facts as tagged in accession 0001104659-15-076315.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-11-05
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001104659-15-076315 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All IVERIC bio, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 450,751,000 | USD | |
| At 2014-12-31 | 479,786,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 367,640,000 | USD | |
| At 2014-12-31 | 351,249,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 83,111,000 | USD | |
| At 2014-12-31 | 128,537,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 254,895,000 | USD | |
| At 2014-12-31 | 39,814,000 | USD | |
| At 2014-09-30 | 94,804,000 | USD | |
| At 2013-12-31 | 210,596,000 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 1,576,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 1,342,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -369,890,000 | USD | |
| At 2014-12-31 | -299,822,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 34,782,000 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 34,432,000 | shares | 273 |
| 2014-07-01 to 2014-09-30 | 33,531,000 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 33,074,000 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 34,782,000 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 34,432,000 | shares | 273 |
| 2014-07-01 to 2014-09-30 | 34,859,000 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 33,074,000 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -1.14 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -2.03 | USD/shares | 273 |
| 2014-07-01 to 2014-09-30 | 0.26 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | -2.57 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -1.14 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -2.03 | USD/shares | 273 |
| 2014-07-01 to 2014-09-30 | 0.25 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | -2.57 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -7,531,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -11,629,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 5,179,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 35,964,000 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 2,590,000 | USD | |
| At 2014-12-31 | 1,555,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 18,474,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 9,492,000 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -47,443,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -82,327,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 13,658,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -49,345,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 288,083,000 | USD | |
| At 2014-12-31 | 473,382,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 34,644,000 | USD | |
| At 2014-12-31 | 19,831,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 50,891,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 129,050,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 25,917,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 88,920,000 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 40,479,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 97,095,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 17,105,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 66,189,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 34,903,881 | shares | |
| At 2014-12-31 | 33,994,520 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 452,887,000 | USD | |
| At 2014-12-31 | 428,390,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 79,000 | USD | |
| At 2015-06-30 | 24,000 | USD | |
| At 2014-12-31 | -65,000 | USD | |
| At 2014-09-30 | 35,000 | USD | |
| At 2014-06-30 | 25,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 3,327,000 | USD | |
| At 2014-12-31 | 1,857,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 737,000 | USD | |
| At 2014-12-31 | 302,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 35,000 | USD | |
| At 2014-12-31 | 100,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 5,541,000 | USD | |
| At 2014-12-31 | 8,812,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -47,104,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -81,697,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 13,731,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -49,156,000 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -39,518,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -69,924,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 8,562,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -85,085,000 | USD | 273 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -39,573,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -70,068,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 8,552,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -85,120,000 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 10,412,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 31,955,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 8,812,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 22,731,000 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 77,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 535,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 36,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 80,000 | USD | 273 |
Inspect the source
- Entity
- IVERIC bio, Inc. / CIK 0001410939
- Captured
- SEC response SHA-256
7aff9f507cfd15a8bd6e8dd99a4dcc039fc9df2e3eccec63317bb71cb3838bcf
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001410939.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))